Neptune Medical Raises $97M, Launches Jupiter Endovascular
19 août 2024 à 13:39
Neptune Medical recently secured $97 million in Series D financing and launched a subsidiary, Jupiter Endovascular Inc., marking a strategic move to enhance its focus on gastrointestinal (GI) robotics while enabling Jupiter to advance in endovascular treatments. Neptune’s founder and CEO, Alex Tilson, emphasized that these developments will allow both companies to innovate within their respective fields.The formation of Jupiter Endovascular follows Neptune’s recent appointment of Dr. Fred Moll, a […]